meRfi®-GM
Cancer microbiome / Tumor microbiota
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
The Cancer microbiome / Tumor microbiota (= Tumor-resident microbes (TRM)) is an integral part of the tumor microenvironment (TME). It can influence Tumor growth, long-distance dissemination, and response to therapies by interfering with molecular signaling pathways in tumor cells and other components of the TME.
Microbial species such as Helicobacter pylori , Colibactin-Producing Escherichia coli / E. coli pks+ , [enterotoxigenic Bacteroides fragilis (ETBF)…
References (Sources)
- Gut microbiome compositional and functional differences between tumor and non-tumor adjacent tissues from cohorts from the US and Spain
- Microbiome and Malignancy
- Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions
- Probing the tumor micro(b)environment
- The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL
- The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy
- The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies